Vermillion Announces First Quarter 2008 Financial Results and Busines...(d for March 4 2008 1 for 10 reverse stoc...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Vermillion Announces First Quarter 2008 Financial Results and Business Progress
Date:5/15/2008
d for March 4, 2008, 1 for 10 reverse stock split.
'/>"/>
| SOURCE Vermillion, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
11. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease
Post Your Comments:
Breaking Biology Technology:miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3
[0] miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease[0] Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans[0] For Release: Esco Announces 2nd North American Facility in Marietta, OH [0] NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont
Other Biology Technology:Premier Research Appoints Global Head of Human Resources 2Bioscrypt's V-Station MIFARE Placed on Transportation Security Administration's Qualified Products List 2Bioscrypt's V-Station MIFARE Placed on Transportation Security Administration's Qualified Products List 3
Breaking Biology News(10 mins):Scientists identify natural anti-cancer defenses 2Moderate weight loss in obese people improves heart function 2Moderate weight loss in obese people improves heart function 3Space agencies join forces to systematically observe climate variables 2Space agencies join forces to systematically observe climate variables 3State Legislators in D C To Blast Senate Healthcare Bill at News Conference 3B Say Tramples States Rights and Saddles with Massive Medicaid Bills 3B 62596 1State Legislators in D C To Blast Senate Healthcare Bill at News Conference 3B Say Tramples States Rights and Saddles with Massive Medicaid Bills 3B 62596 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High Concentration DCVax 28R 29 Manufacturing 6748 1Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High Concentration DCVax 28R 29 Manufacturing 6748 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High Concentration DCVax 28R 29 Manufacturing 6748 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High Concentration DCVax 28R 29 Manufacturing 6748 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High Concentration DCVax 28R 29 Manufacturing 6748 5North American Seminars Inc Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 62590 1North American Seminars Inc Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 62590 2North American Seminars Inc Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 62590 3North American Seminars Inc Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 62590 4
Other Biology News:Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery 2Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery 3In the sea slug's defense against lobsters, confusion is key 2Scientists decipher genome of fungus that can cause life-threatening infections 2Scientists decipher genome of fungus that can cause life-threatening infections 3Scientists decipher genome of fungus that can cause life-threatening infections 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |